Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2017; 42(4): 559-562


Effectiveness of Kaltenborn mobilization in mid-range and end-range in patients with adhesive capsulitis

Fareeha Kouser, Abdul Ghafoor Sajjad, Sumera Amanat, Qamar Mehmood.




Abstract

Objective: To compare the effectiveness of mid-range mobilization vs end-rang mobilization in treating pain, range of motion and functional status.
Methodology: It was a Randomizes Control trial in which 37 patients were randomly assigned; 18 in the experimental group and 19 in control group. The study was conducted at the Department of Physiotherapy, National Institute of Rehabilitation Medicine, Islamabad, Pakistan from October 2015 to January 2016. Inclusion criteria for the study was age between 30 and 60 years, minimum 50% reduction in ROM, Frozen and Thawing stage and positive capsular pattern and Apley’s scratch test. Patients with age below and above 30-60 years, restricted ROM due to trauma, dislocation or fracture, malignancy and any neuromusculoskeletal or cardiovascular condition were excluded. Outcome measuring tools were numeric pain rating scale (NPRS), goniometer and SPADI. Data were analyzed using SPSS version 20.
Results: The results were significant (p0.05).
Conclusion: End-range mobilization is more effective in improving ROM and disability.

Key words: Adhesive capsulitis, End Range Mobilization, Mid-range Mobilization






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.